Monitoring trials in real time may help shorten the time interval between trial phases.
Food and Drug Administration Commissioner Marty Makary.BRENDAN SMIALOWSKI/AFP via Getty Images
By Lizzy Lawrence
April 28, 2026
FDA Reporter
Lizzy Lawrence
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to…
Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug…
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed…
The FDA is looking to get thrifty with its approved drugs. | The framework would leverage existing safety data on approved drugs…
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
